Paper Details

  1. Home
  2. Paper Details

Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.

Author: CohenS, LevyR, SpeiserZ

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Rasagiline, a MAO-B inhibitor, restored normal motor activity in animal models of drug-induced dopaminergic dysfunction. It also improved cognitive and memory deficits in rats exposed to prolonged hypoxia.
Paper Details　
Original Abstract of the Article :
N-propargyl-1-(R)aminoindan (rasagiline) is a new and selective irreversible MAO-B inhibitor, currently being considered as the mesylate salt for potential therapy in certain neurological disorders. It has been studied in animal models of cognition and motor dysfunction. Its ability to restore norma...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/978-3-7091-6499-0_29

データ提供：米国国立医学図書館（NLM）

Exploring the Effects of Rasagiline in Neurological Disorders

This research delves into the exciting world of neurology. The study uses animal models to investigate the potential of rasagiline, a selective MAO-B inhibitor, in treating neurological conditions like Parkinson's disease. The researchers used a variety of models, including those with drug-induced dopaminergic dysfunction, hypoxia-induced memory impairment, and drug-induced catalepsy. They found that rasagiline effectively restored normal motor activity and improved cognitive function in these models. The study also compared rasagiline to other MAO-B inhibitors, highlighting its unique properties and effectiveness.

Rasagiline: A Promising Hope for Neurological Disorders

The results of this study suggest that rasagiline holds promise as a treatment for neurological disorders. It effectively tackled motor and cognitive dysfunction in animal models, suggesting its potential in real-world scenarios. Rasagiline's effectiveness in reversing drug-induced dopaminergic dysfunction is particularly encouraging, as it might offer relief to individuals experiencing Parkinson's-like symptoms.

The Importance of Further Research in Neurodegenerative Diseases

While this study offers compelling evidence for rasagiline's potential, it is crucial to remember that this research was conducted in animal models. Further research is necessary to confirm its safety and efficacy in humans. This study provides valuable insights for future clinical trials and paves the way for exploring new avenues for treating neurological disorders.

Dr.Camel's Conclusion

Rasagiline is a promising drug for neurological disorders, but more research is needed to confirm its safety and efficacy in humans. The researchers used animal models to assess its effects and observed positive results, which is a promising sign. However, it is essential to conduct human clinical trials to further validate its therapeutic potential.

Date :
  1. Date Completed 1998-06-10
  2. Date Revised 2019-10-24
Further Info :

Pubmed ID

9564629

DOI: Digital Object Identifier

10.1007/978-3-7091-6499-0_29

Related Literature

Article Analysis
・Effects of rasagiline
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.